<SEC-DOCUMENT>0001019687-13-003163.txt : 20130919
<SEC-HEADER>0001019687-13-003163.hdr.sgml : 20130919
<ACCEPTANCE-DATETIME>20130815135159
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001019687-13-003163
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20130815

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AETHLON MEDICAL INC
		CENTRAL INDEX KEY:			0000882291
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				133632859
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		8910 UNIVERSITY CENTER LANE, SUITE 660
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
		BUSINESS PHONE:		858-459-7800

	MAIL ADDRESS:	
		STREET 1:		8910 UNIVERSITY CENTER LANE, SUITE 660
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BISHOP EQUITIES INC
		DATE OF NAME CHANGE:	19930602
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;<BR CLEAR="ALL">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 35%; font-size: 10pt">&nbsp;<IMG SRC="image_001.jpg" ALT=""></TD>
    <TD STYLE="width: 65%; font-size: 10pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>8910 University Center Lane, Suite 660</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>San Diego, CA 92122</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>858-459-7800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>858-272-2738 (fax)</B></P>


</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0"><B><U>VIA EDGAR CORRESPONDENCE</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">August 15, 2013</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">Division of Corporate Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">U.S. Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">Mail Stop 4561</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">100 F Street N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">Washington, D.C. 20005</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">Attn: &#9;&nbsp;&nbsp;Ms. Kaitlin Tillan, Assistant Chief Accountant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.3in">&nbsp;&nbsp;&nbsp;Ms.
Jeanne Bennett, Staff Accountant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0.4in"><B>RE:&#9;&nbsp;&nbsp;&nbsp;&nbsp;Aethlon Medical, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in"><B>Form
10-K for the Fiscal Year Ended March 31, 2013</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.8in"><B>File No. 000-21846&#9;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">Dear Ms. Tillan and Ms. Bennett:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0; text-align: justify">We are writing in connection with the above-captioned
matter regarding Aethlon Medical, Inc.&rsquo;s (the &ldquo;Company&rdquo;) disclosure in its Annual Report on Form 10-K for the
fiscal year ended March 31, 2013 regarding the Company&rsquo;s disclosure under Item 8 Financial Statements. We hereby provide
supplementally the following responses in reply to the Staff&rsquo;s comment letter dated August 1, 2013 (the &ldquo;Comment Letter&rdquo;).
The numbered responses set forth below correspond to the numbering set forth in the Comment Letter. For your convenience, we have
included each of the Staff&rsquo;s comments before the relevant response.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Form 10-K for the Fiscal Year Ended March 31, 2013</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Item 8. Financial Statements</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Note 1. Organization and Summary of Significant Accounting
Policies</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><U>Revenue Recognition, page F-11</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I><U>Comment No. 1</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We note that you are using the milestone
method of revenue recognition for your DARPA contracts. Please explain your basis for using this method for these contracts. Refer
to FASB ASC 605-28 and 605-35.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I><U>Response</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has one contract with DARPA,
which is a fixed-price contract. The Company considered the percentage of completion (&ldquo;POC&rdquo;) method and completed contract
revenue recognition methods for the DARPA contract noting that they are only preferable when reasonably dependable estimates can
be made. The term &ldquo;reasonably dependable estimates&rdquo; encompasses the extent of progress toward completion, contract
revenue, and contract costs; thus, it covers an entity&rsquo;s entire contract administration and management control system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on the fact that the Company has
not been engaged on a continuing basis or otherwise to perform under any such contractual arrangements (thus has no history of
demonstrating the ability to reasonably estimate costs), it appears that there is persuasive evidence (which is required by GAAP)
to overcome the presumption that management has the ability to make such estimates. Absent the ability to generate &ldquo;reasonably
dependable estimates,&rdquo; the Company may not use the percentage of completion method or completed contract method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has analyzed its revenue recognition
policy and noted the following as they pertain to FASB ASC 605-28 Milestone Method:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to account for this contract,
the Company identifies the deliverables included within the contract and evaluates which deliverables represent separate units
of accounting based on certain criteria, including whether the delivered element has standalone value. The consideration received
is allocated among the separate units of accounting, and the applicable revenue recognition criteria are applied to each of the
separate units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A milestone is an event having all of
the following characteristics:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">There is substantive uncertainty at the date the arrangement is entered into that the event will
be achieved. A vendor&rsquo;s assessment that it expects to achieve a milestone does not necessarily mean that there is not substantive
uncertainty associated with achieving the milestone.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">The event can only be achieved based in whole or in part on either: (a) the vendor&rsquo;s performance;
or (b) a specific outcome resulting from the vendor&rsquo;s performance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">If achieved, the event would result in additional payments being due to the vendor.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A milestone does not include events for
which the occurrence is either: (a) contingent solely upon the passage of time; or (b) the result of a counterparty&rsquo;s performance.
The policy for recognizing deliverable consideration contingent upon achievement of a milestone must be applied consistently to
similar deliverables.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><BR>
As noted below, a milestone must be determined to be substantive in order to use the milestone method. The assessment of whether
a milestone is substantive is performed only at the inception of the arrangement. The consideration earned from the achievement
of a milestone must meet all of the following for the milestone to be considered substantive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">The consideration is commensurate with either: (a) the vendor&rsquo;s performance to achieve the
milestone; or (b) the enhancement of the value of the delivered item or items as a result of a specific outcome resulting from
the vendor&rsquo;s performance to achieve the milestone;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">The consideration relates solely to past performance; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">The consideration is reasonable relative to all of the deliverables and payment terms (including
other potential milestone consideration) within the arrangement.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A milestone is not considered substantive
if any portion of the associated consideration relates to the remaining deliverables in the unit of accounting (i.e., it does not
relate solely to past performance). To recognize the milestone consideration in its entirety as revenue in the period in which
the milestone is achieved, the milestone must be substantive in its entirety. Any one milestone and its related consideration cannot
be bifurcated into substantive and non-substantive components. In addition, if a portion of the consideration earned from achieving
a milestone may be refunded or adjusted based on future performance, the related milestone is not considered substantive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company analyzed each milestone, including
in depth discussion with Dr. Richard Tullis, the Company&rsquo;s Chief Science Officer, reviewing whether the consideration was
commensurate with either (1) the entity's performance to achieve the milestone, or (2) the enhancement of the value of the delivered
item(s) as a result of a specific outcome resulting from the entity's performance to achieve the milestone; the consideration
related solely to past performance; and the consideration is reasonable relative to all of the deliverables and payment terms
(including other potential milestone consideration) within the arrangement. The Company considered the following factors in order
to conclude that each milestone was substantive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The degree of certainty in achieving the
milestone. .</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Whether the Company&rsquo;s efforts lead
to achievement of the milestone.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Whether substantive effort is required
to achieve the milestone. .</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Whether the amount of the milestone payment
is reasonable relative to (a) the Company&rsquo;s efforts required to achieve the milestone or (b) the enhancement of value of
the delivered item(s) resulting from the Company&rsquo;s efforts.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Whether any portion of the milestone payment
is related to future performance or deliverables.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Whether the amount of the milestone payment
is reasonable relative to the other deliverables and other payment terms of the arrangement.</FONT></TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company believes the milestone method
is appropriate and being properly applied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I><U>Comment No. 2</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Further, please explain how the company considers provisions
for losses on contracts in its revenue recognition policy and revise your disclosure in future filings accordingly. Refer to FASB
ASC 605-35-25-45 through 25-50.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I><U>Response</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company presently does not have any contracts accounted
for under the percentage-of-completion or completed-contract methods. However, if the Company had and accounted for contracts under
such methods, it would provide for losses in the current period when they become apparent from the estimate process in accordance
with FASB ASC 605-35-25-45 through 50.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Under FASB ASC 605-35-25-1, we note the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>In accounting for contracts, the basic
accounting policy decision is the choice between two generally accepted methods: the percentage-of-completion method including
units of delivery and the completed-contract method. The determination of which of the two methods is preferable is based on a
careful evaluation of circumstances because the two methods should not be acceptable alternatives for the same circumstances.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In particular, FASB ASC 605-35-25-45, indicates:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>For a contract on which a loss is anticipated,
GAAP requires recognition of the entire anticipated loss as soon as the loss becomes evident. An entity without the ability to
update and revise estimates continually with a degree of confidence could not meet that essential requirement of GAAP.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The milestone method, unlike the percentage-of-completion
and completed contract-method noted above, does not take on an element of profit or loss estimate and therefore has no provision
for losses inherent in the process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We will add disclosure in future filings
regarding our policy on provision for losses on contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I><U>Comment No. 3</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We note that you have two different types of contracts: fixed-price
and cost-reimbursable. Please explain to us the difference in how you recognize revenue for each type of contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I>&nbsp;</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B><I><U>Response</U></I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As we noted in our responses to Comments number 1 and 2, we
have one fixed-price contract in place, our contract with DARPA, on which we recognize revenue under the milestone method.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In our Form 10-K for the fiscal year ended March 31, 2013, we
disclosed that &ldquo;DARPA recently awarded a related contract for $22,830,840 to Battelle Memorial Institute (&ldquo;Battelle&rdquo;)
to be the systems integrator for the various components being developed under the original contract, including our two components
of the project. We agreed to become a subcontractor to Battelle under that systems integrator contract.&rdquo; That subcontract
will be under a time and materials basis and we expect to begin generating revenues under the subcontract during the fiscal year
ending March 31, 2014. We did not record any revenue from that subcontract in the three months ended June 30, 2013. Our expected
revenue from the subcontract will be at the discretion of Battelle. The Battelle subcontract is our first cost-reimbursable contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We did not record any revenue from the Battelle subcontract
in the June 2013 quarter but did make our first invoice to Battelle in July. Our revenue under this contract will be a function
of cost reimbursement plus an overhead mark-up for hours devoted to the project by specific employees (with specific hourly rates
for those employees), for travel expenses related to the project, for any equipment purchased for the project and for the cost
of any consultants hired by us to perform work on the project. Each payment will require approval by the program manager at Battelle.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">While we have not concluded our final revenue recognition policy
for the Battelle subcontract, we expect that it will be based upon our invoices to Battelle with the revenue presented in our statements
of operations as part of our government contract revenue.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company hereby acknowledges that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD STYLE="text-align: justify">The Company is responsible for the adequacy and accuracy of the disclosure in the Company&rsquo;s
Form 10-K for the fiscal year ended March 31, 2013;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD STYLE="text-align: justify">Staff comments or changes to disclosure in response to staff comments do not foreclose the Commission
from taking any action with respect to the filing; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD STYLE="text-align: justify">The Company may not assert staff comments as a defense in any proceeding initiated by the Securities
and Exchange Commission or any person under the federal securities laws of the United States.</TD></TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0; text-align: justify">We hope that the foregoing is responsive to the Staff&rsquo;s
comments. Please do not hesitate to contact me at (858) 459-7800 (extension 300) if you have any questions regarding this matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 5in">Very truly yours,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 5in"><I><U>/s/ Jim Frakes</U></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 5in"><I></I>James
B. Frakes</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 5in">Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 5in"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2.9pt 0pt 5in"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``H'!P@'!@H("`@+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!#`0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P``1"`!(`,4#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#V:BBB@`HH
MHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*2D9@JDL<`#))[5YIXM\?S7$D
MEAHTIC@'RO<+PS_[OH/>MZ%"=>7+`RJU8TU=G:ZMXJT;1B4N[Q/-'_+*/YG_
M`"'3\:YJX^*EDK$6^F7$@[%W"?XUYJ26)9B23R23DFDKW*>648KW]3SI8RH]
MM#TB+XJVQ;$VDS*/5)0W]!6_I?C?0M5=8TNO(E;I'<#83]#TKQBCK3GEE"2]
MW04<746^I]#@@]#17C_ACQM>Z)(EO=,]S8]"C'+1CU4_TKUJSNX+ZUCN;:02
M0R+N5QT(KQ,3A9T)6EMW/1I5HU5IN3T445S&P45'//#:P///(L44:EG=SA5`
MZDFN:E^)G@N&38WB"V)SCY`S#\P,4`=315'2]:TS6[;[3I=]#=Q`X+1/G!]#
MZ5%J'B+2-*E$5]J$,,A_@+9;\A3C&4G:*N)M+5FG15"PUK3=4C:2QO89U3EM
MC<K]1UKB%^*]@WCQM,-_IZZ(D&\7FXY9\#Y<YQUSVH::=F":>J/1J*\J^+^O
MQ7G@G3]0T/4RT3WX3SK:4@'"-D9'O79W7C3PYH4,%OJFL6\$_E*3&6+..!U`
MR1^-(9T5%9FC^(]&\01L^DZE!=A/O"-N5^HZBN$\27=U'\<O#ULES,L#V^6B
M60A&_P!9U'0T`>G45!>7MKI]J]U>W$5O`@RTDK!5'XFN?C^)/@V6<0KX@M=Y
M./FW!?\`OHC'ZT`=/13$ECEC62-U=&&593D$>H-92>+O#TEA/?KK%H;6W?RY
M9?,`56_N_7VH`V**YNS^(GA"_N5MK?7K4RL=JAB4R?8L`*Z.@#A?B1X@:TM4
MTBV?;+<+NF(/(3T_'^0KS*M7Q/?-J/B2^N"<CS2B>RKP/Y5K>`-`_M;6?M<R
M9MK,ACD<,_\`"/ZU]/14,+AN9^OS/&J-UJMD16_P^\17$"3"WB0.,A9)0&'U
M':I/^%<>(_\`GE;?]_O_`*U>NBAB%4DD`#J37E_VI7\CM^IT_,\4U7P=K6C6
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M_2KWASQ7\/=,TRV@TB^L[59`JK$J$2LQ[,,9)S2&<5X"U&33_%_B^[33FTQ4
MM6F6Q(QY1W`J"/7G]:Z7PCJ-A9637MYIFH7E_<NSR7*VAD!YX`:L_P`/6:ZA
M\6/&MFYPL]N4)],[>:W/#7B&+PU;'0?$!:SEMG;RI74[)%)SP:[:&M*22N[K
MUL<M72HFW9%74+@7/BK3-1T?2;^W?S!'=%[5HU="0.?7@FLB'1-)/QYGT\Z9
M:&S%@&%OY"^6#L7G;C&:]"M/%VB:A?Q65C>BYFES@1J2!@9R3TKSO6M9M/"W
MQU.IZL7@LY[((LVPD<J!GCJ,C%95Y2?*I1M8TI12NT[W+'QNLK33O!.GV]C:
MPVT(U`$1PH$4$H_85U7A?P)H>G:+`UWI]O?7L\2O<W-S&)7D<C)Y;.!S7&?%
M_7-/\1>`=/O]+G,]L=1V"385R0C9X/->L6/_`!X6_P#UR7^0KG-CR>?2[3PM
M\=M)BT>,6L%_`3+#'PG(<$`>GR@X]:N>)_\`DO?AS_KV_P#CE'BG_DO/AK_K
MW_\`CE'B?_DO?AS_`*]O_CE`">)(SXR^+UKX9O6<Z5IT'VB6$'`E;&>?S4?3
M/K7=W?@[PY>:<;";1;+R"NT*D"J5]P0,@^]<1XSM[SPC\0[3QS!:RW6G2Q>1
M?+$N6C&,9^F,'ZCWK;N?BYX.AT\W46I&YD*Y2WCB;S&/I@CC\:`,;X4W5QIN
ML^(/!\T[3PZ9,6MF8Y(7<01_(_4FN=^$OA6SU^]U.\U6/[5:6=R1#;2<QF1N
MK%>A(``Y]:ZSX6Z)J(FU?Q5J\#6]SK,I>.%AADCR3DCMG/Y"JGP._P"05K?_
M`&$#_P"@T`6OBGX0T'_A"+Z_@TRVMKFS57BD@B"'[P!!QU&#71?#^[GOO`&C
MW%PY>5K8*6)R3@D#]!5?XH_\DXUG_KDO_H:T_P"&?_).M%_ZX'_T(T`>3M#+
M<:@T,:%Y9)BJJ.I)->V>'=&CT+1H;),%P-TK?WG/4_T_"N<\.>$FM?%VHZC<
MQXB@F;[-D?>+<[OP!Q]?I7;UZ>.Q*J<L([(XL+1Y+R>X5Y]\8?%IT#PU_9UJ
MY6\U,&,$=4C_`(C^.<?B?2N^GFCMX7FE8)'&I9F/8#K7@/C:[?Q9=W-RW8_Z
M.I_A4=!^/]:Y:&&G7YN7I_5C>I6C3:3ZGFM>@^$;_P#MOP]+HTAW7NF!I[3/
M5X>LB?@?F'MFO/V!#$$8(."*N:1JESHNK6VI6C;9K:0.N>A]0?8C(/UK.E4E
M2FIKH7."G%Q9V]%7M3CMG,&HZ?\`\>&H1^=`/[G]Y#[JV1^55(HGN)DAC&7D
M8*H]23BOK:=2,X*:V9X4HN+<6>W^%L_\(MIN[.?LZ]?I15ZQMA9V,%JO2&-4
M'X#%%?'S?-)L]Z*M%(G*A@0P!!&"#5--&TJ.42QZ99I(#D.L"@@^N<5=HJ2B
M,0Q*YD6-`[=6"C)_&DFMH+A=LT,<H'9U#?SJ6B@"&*TMK?\`U-O%%_N(%_E3
M;FPL[U5%W:07`7H)8P^/SJQ10!G7D^D:3;PQW2V]O"\@2)#&-NX]@`.*=)K.
MG07K6,ERBW"1&5H^<A!WJAXGT>36HK2W1,H)'+MG[F8V`/\`WT16+9Z#K#W'
MV^]@!NI[:X2;##Y2558U_3/XUTPITW&\I:F$IS4K)&_#XAT*[WW,<R/Y,9D:
M4PL-J#J<D?RI]KKNB:C=`03QO.$++NC*L5'4C(&?PK!LM,U1?#%SIDEI>B9K
M$Q+YUPC1[L8PH!X_&K(L=4U*;2Q-IYLX].0EI))%9I&V;=J@=O7-5*E35[/\
M4)5)Z:?@:\OB#24LH;E[M##<Y$6%),GKA<9/Y57>7PU96::N]O9P1,V%G-L%
M;.?IG-8^FZ1JNDC2;[[#]I>VM7MYK=9%#IEMP92>#Z&K=]INI>(M1@:XCETZ
MTMXBR@['9I&R.1R.%_G4NG34M].]P4YVVU-\ZC9BY@M_.7S;E"\2_P!]1R2/
MS%31Q11`^5&B9Y.U0,UQMGIVMZ==Z8\FGO=KIHG@#)(H+H<;#R?3^5=/8Z@]
MY/+"UE/;M"JEC)C&XC.T$=<=_K45*:C\+O\`\.7"=]QMYK.E6Z727=Q&%M0I
MG#*2$#?=SQWJ6._L5-M%%+&!<(7A"]&4#)(_.N=U;1+^ZN]9:.W#I=&V\K+#
MY@A&ZH_^$;U"'5_LD/\`R"UAG$$N[YH#(N-F.N`>1]:T5*DU\6O_``/\R/:3
MOM_5SH+37],OKH6UK<^:Y)`*HVTXZX;&/UK1K!T*34K"QM],N-'9#;1;/.CE
M0QM@<8YSS].]:C7DL>EM>36LB2+$7:!?G8''W>.IK&<4I6C^9I"5U=G&_$K7
M_(M4T:W?$DXWSX[)V'XG^5>:5:U.^GU/4KB\N<^=*Y+`_P`/H/PZ55KZG"T%
M1I*/7J>-6J>TFY'+>(]/\BY%U&/W<Q^;'9O_`*]8N*[ZYMHKN`PS+N0U0_X1
MW31_!)_W\KS<3ETYU'*G:S.REBXQ@E/<L>`]0%_;3^&+AANF)GL&8_=F`Y3Z
M.H_,"O0?AUX>>\U+^UKB,B"U)$88?>D_^M_.L+PC\+?[2O(-0=+BRMHG$BR[
MR'8@Y&W_`!KVR*)(4"1J%7K@#'/>N1UIX>G*A=._;IW-E3C5FJEA]%+17GG6
M%%%%`!1110`4444`)BC%%%`!@48HHH`,48HHH`,48Q110`4444`&*,444`9&
MK>%=&UDE[NS7S3_RUC^5_P`QU_&N:G^%=DS$V^ISQCL'0/C^5%%;T\56IJT9
M&4J-.6K0R+X56X;,VK2L/1(@O\R:W]+\$:%I;K(EIY\J]))SO(^@Z?I113GB
:Z]16E(4:%.+T1T```P!2T45SFP4444`?_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
